Mergers & Acquisitions
FTC to Closely Examine Pfizer, Mylan Deal
By David Hatch
|
Published: October 29th, 2019
The transaction faces other regulatory hurdles, including a review by China, possible Brexit complications and clearances in nearly two dozen jurisdictions.
